Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Christoph Wanner"'
Autor:
Colin Baigent, JonathanR. Emberson, Richard Haynes, William G. Herrington, Parminder Judge, Martin J. Landray, Kaitlin J. Mayne, Sarah Y.A. Ng, David Preiss, Alistair J. Roddick, Natalie Staplin, Doreen Zhu, Stefan D. Anker, Deepak L. Bhatt, Martina Brueckmann, Javed Butler, David Z.I. Cherney, Jennifer B. Green, Sibylle J. Hauske, Hiddo J.L. Heerspink, Silvio E. Inzucchi, Meg J. Jardine, Chih-Chin Liu, Kenneth W. Mahaffey, Finnian R. McCausland, Darren K. McGuire, John J.V. McMurray, Bruce Neal, Brendon L. Neuen, Milton Packer, Vlado Perkovic, Marc S. Sabatine, Scott D. Solomon, Muthiah Vaduganathan, Christoph Wanner, David C. Wheeler, Stephen D. Wiviott, Faiez Zannad
Publikováno v:
The Lancet. 400:1788-1801
Large trials have shown that sodium glucose co-transporter-2 (SGLT2) inhibitors reduce the risk of adverse kidney and cardiovascular outcomes in patients with heart failure or chronic kidney disease, or with type 2 diabetes and high risk of atheroscl
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 146:317-322
Kidney patients age faster and vascular risk factors intensify the process. Lifetime is reduced up to 16 years in patients with diabetes mellitus type 2 and kidney disease. SGLT2 inhibitors play a significant role in maintaining organ function. By in
Autor:
Christoph Wanner
Publikováno v:
The American Journal of Medicine. 130:S63-S72
There is increasing evidence that sodium glucose cotransporter 2 (SGLT2) inhibitors have renoprotective effects, as demonstrated by the renal analyses from clinical trials including Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes
Autor:
Paola Romagnani, Giuseppe Remuzzi, Richard Glassock, Adeera Levin, Kitty J. Jager, Marcello Tonelli, Ziad Massy, Christoph Wanner, Hans-Joachim Anders
Publikováno v:
Nature Reviews Disease Primers
Nature reviews. Disease primers, 3:17088. Nature Publishing Group
Nature reviews. Disease primers, 3:17088. Nature Publishing Group
Chronic kidney disease (CKD) is defined by persistent urine abnormalities, structural abnormalities or impaired excretory renal function suggestive of a loss of functional nephrons. The majority of patients with CKD are at risk of accelerated cardiov
Autor:
Detlef H. Krieter, Bernard Canaud, Gerd-Peter Dragoun, Kai von Appen, Christoph Wanner, Annie Rodriguez, Horst-Dieter Lemke, Andreas Morgenroth
Publikováno v:
Artificial Organs. 37:283-290
The estrogenic endocrine-disrupting substance bisphenol A (BPA) is extensively used as a starting material for a variety of consumer plastic products including dialyzer materials. The present study was performed to explore plasma BPA levels in patien
Publikováno v:
Kidney and Blood Pressure Research. 29:329-337
Background/Aim: Hypertension is one of the main cardiovascular risk factors and has an impact also on long-term kidney graft survival. In addition to their lipid-lowering properties, it was shown that 3-hydroxy-3-methylglutaryl coenzyme A reductase i
Autor:
Juan Politei, Maria Dolores Sanchez-Niño, Alberto Ortiz, David G. Warnock, Christoph Wanner, Frank Weidemann, João Paulo Oliveira
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Orphanet Journal of Rare Diseases
instname
Orphanet Journal of Rare Diseases
Fabry disease is a rare X-linked hereditary disease caused by mutations in the AGAL gene encoding the lysosomal enzyme alpha-galactosidase A. Enzyme replacement therapy (ERT) is the current cornerstone of Fabry disease management. Involvement of kidn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3067ede5ad04757ca78ee1df250165e
https://doi.org/10.1186/1750-1172-8-116
https://doi.org/10.1186/1750-1172-8-116
Autor:
Anders H. Berg, David J. Friedman, Sahir Kalim, Samir M. Parikh, Wenda Ramma, Tammy Hod, S. Ananth Karumanchi, Christiane Drechsler, John Danziger, Christoph Wanner, Hanno Steen, Julia Wenger, Roberto Buccafusca, Ravi Thadhani
Publikováno v:
Science Translational Medicine. 5
Urea, the toxic end-product of protein catabolism, is elevated in end-stage renal disease (ESRD), although it is unclear whether or how it contributes to disease. Urea can promote the carbamylation of proteins on multiple lysine side chains, includin
Autor:
Kerstin Möller-Ehrlich, Rainer H. Böger, Edzard Schwedhelm, Christoph Wanner, Christoph Sauvant, Boris Betz, Reinhard Schneider, Joachim Kniepert, Tobias Kress
Publikováno v:
Translational research : the journal of laboratory and clinical medicine. 162(2)
Availability of L-arginine, the exclusive substrate for nitric oxide synthases, plays an important role in kidney ischemia/reperfusion injury. The endogenous L-arginine derivatives asymmetrical dimethylarginine (ADMA) and symmetrical dimethylarginine
Autor:
Christoph Wanner, Jonathan L. Isaacsohn, Claudio Gimpelewicz, Hallvard Holdaas, Claudia Abletshauser
Publikováno v:
Renal failure. 28(6)
A pooled analysis was designed to evaluate the effects of fluvastatin on the kidney, in terms of renal adverse events, laboratory abnormalities, and renal function over time. An analysis of adverse events was performed on data from 30 completed clini